Lv65
1880 积分 2024-01-14 加入
Selective and Bioavailable HDAC6 2-(Difluoromethyl)-1,3,4-oxadiazole Substrate Inhibitors and Modeling of Their Bioactivation Mechanism
1天前
待确认
Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase 6
1天前
待确认
Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities
2天前
已完结
LncRNA SNHG11 enhances bevacizumab resistance in colorectal cancer by mediating miR-1207-5p/ABCC1 axis
3天前
已完结
Global Profiling Lysine Reactivity and Ligandability with Oxidant-Triggered Bioconjugation Chemistry
3天前
已完结
Proteome-Wide Ligand and Target Discovery by Using β-Nitrostyrene Electrophiles:Supporting Targeted Protein Degradation
3天前
已完结
Exosomal circ_001860 Promotes Colorectal Cancer Progression through the miR-582-5p/ZEB1 Axis
3天前
已完结
Discovery of AMG 193, an MTA-Cooperative PRMT5 Inhibitor for the Treatment of MTAP-Deleted Cancers
3天前
已完结
A patent review of PRMT5 inhibitors to treat cancer (2018 - present)
9天前
已完结
A patent review of small molecular inhibitors targeting EGFR exon 20 insertion (Ex20ins) (2019-present)
9天前
已完结
皖公网安备34019202002308
